Prostate cancer, comorbidity, and the risk of venous thromboembolism: A cohort study of 44,035 Danish prostate cancer patients, 1995‐2011

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|20|3692-3699

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.20, 2015-10, pp. : 3692-3699

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comorbidity and the risk of venous thromboembolism in prostate cancer

By  

CANCER, Vol. 121, Iss. 20, 2015-10 ,pp. : 3574-3576

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration‐resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance)

By  

CANCER, Vol. 121, Iss. 7, 2015-04 ,pp. : 1025-1031

John Wiley & Sons Inc

Access to resources Recommend Favorite

Selecting patients for prostate cancer treatment: the role of comorbidity

By  

BJU INTERNATIONAL, Vol. 121, Iss. 2, 2018-02 ,pp. : 164-165

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set

By  

Urologia Internationalis, Vol. 98, Iss. 1, 2016-07 ,pp. : 22-27

Karger

Access to resources Recommend Favorite

Treatment of Venous Thromboembolism in Cancer Patients

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 66-70

Karger

Access to resources Recommend Favorite